Mr. Duane Poliquin reports

ALMADEN ANNOUNCES EXTENSION OF CURE PERIOD FOR NYSE AMERICAN LISTING

Almaden Minerals Ltd., further to its press release of April 21, 2023, has received an extension of its cure deadline from Oct. 19, 2023, to April 19, 2024.

As previously announced, Almaden is not in compliance with the continued listing standards of the NYSE American exchange because the company's securities have been selling for a low price per share for a substantial period of time which NYSE American determines to be a 30-trading-day average price of less than 20 U.S. cents per share. The company's continued listing on the NYSE American exchange is predicated on it demonstrating sustained price improvement within a reasonable period of time which the staff has determined to be no later than April 19, 2024.

Almaden is considering its alternatives with respect to the requirement that it regain compliance with the NYSE American's continued listing standards within the new cure deadline.

We seek Safe Harbor.